Q2 FY2026 EarningsQ2 FY26 results beat consensus on both top and bottom lines: revenue $4.37B vs. $4.30B expected (+1.5%), and Adjusted EPS $3.15 vs. $3.03 expected (+3.9%). R&D Solutions drove growth with record net new bookings of $3.15B (1.22x book-to-bill), and Commercial Solutions saw a strong 8.6% YoY increase. Management raised FY26 revenue and profit guidance, signaling robust demand for AI-driven healthcare intelligence and clinical services.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: IQVIA(IQV) the Revenue is 4.368 B (+8.74%), Beat estimate;the EBIT is 506 M (+0%), Miss estimate;the EPS is 1.53 (-0.65%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
4.37B8.74%
4.30B7.10%
+0.07B1.64%
EBITMiss expectations
0.51B--
0.63B24.03%
-0.12B24.03%
EPSMiss expectations
1.530.65%
1.900323.39%
-0.370324.04%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf